Story Poster

BREAKING: Dawgs Land GAME-CHANGING DL Bear Alexander

February 2, 2021

Get our insider newsletter today

The Georgia Bulldogs pick up even MORE momentum in the 2022 class with a GIANT commitment from one of the top defensive line prospects in the country.

That would be four-star, Bear Alexander‍.

The massive 6-foot-3 325-pounder is the ideal replacement for senior Jordan Davis in 2021 and should fill the middle of Georgia’s defensive line nicely over the next few years.

The Ryan (TX) standout played on one of the top teams in Texas last year, and while he only played a few games, he helped lead his team to the Texas 5A D-I state championship. 

There isn’t a ton of film out there on “The Bear”, but sources in the area have told Dawg Post he can be “unblockable” at times. He dominated at Terrell High School as a freshman and was named the district’s Newcomer of the Year after the 2018 season. Alexander missed time due to transfer rules as both a sophomore and a junior, but that hasn’t slowed down his recruitment.

The Georgia staff worked out Alexander, who has ties to the peach state, back in the summer of 2019 where his relationship with Georgia defensive line coach Tray Scott really took off. 

As a prospect, Alexander is exactly what you look for in a true nose tackle at the next level. He has the size, he has the strength, and he has incredible quickness off the ball for someone his size. He can get into the backfield in a flash and totally disrupt plays from the start. He’s not as tall as former Bulldogs who have played nose guard, but he plays with excellent leverage that should still translate well to the next level.

What stands out the most is his quickness for someone at 325-pounds. He’s reliable in pursuit and knows how to deliver a blow once he gets to the ball carrier. 

This is a MASSIVE pickup for the Bulldogs and one of the biggest pieces to the future of Georgia’s defense.


subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.